Therapeutic Advances in Vaccines and Immunotherapy
@TAVaccinesImm
A @SAGE_Publishing gold open access journal | Publishing high-quality articles in the fields of vaccinology and immunotherapy | PubMed indexed | #TAVaccinesImm
🚨 New Publication Alert! 🚨
Explore vaccination practices & knowledge among adults with hemoglobinopathies in Greece 🇬🇷 in a comprehensive nationwide survey by Sophia Delicou et al.
Read the full study here: https://t.co/2d4MBO5D0i #Vaccination#Hemoglobinopathies#PublicHealth
New publication alert!
Adjuvants in COVID-19 vaccines: innocent bystanders or culpable abettors for stirring up COVID-heart syndrome - Sri Harsha Kanuri, Prapthi Jayesh Sirrkay, 2024 https://t.co/S8RNQOgbVS
📣Calling all experts in #globalhealth and infectious diseases! Our special collection 'Global Health: Travel Vaccines and Infectious Disease' is now open, in partnership with @TAInfDis🌍💉🦠
🔸 Guest Editor: Dr Nelson Agudelo @OUHealth
🔸 Info: https://t.co/seEWzDY5Yo
Stagnation or safety? Reassessment of the human papillomavirus vaccination dosing regimen in Japan - A Letter to Editor by Mira Namba, Yudai Kaneda, Miho Iida, 2023 https://t.co/I1xh3lLZNg
Our latest publication by @LoubnaAlj et al. delves into vaccine safety, emphasizing preventive actions during immunization to avoid adverse reactions. Prompt reporting of incidents, especially serious ones, is crucial for risk minimization.
Read here: https://t.co/k4kEAJeE6g
The world’s first #malaria vaccine has reached over 2 million children in Ghana, Kenya and Malawi.
Data shows the vaccine reduced child mortality from all causes by 13%! https://t.co/sQFVGwme2p @WHOAFRO#VaccinesWork#endmalaria
Fighting and treating cancer requires multiple perspectives and disciplines.
Learn about 5 counterintuitive ways scientists are approaching cancer research to improve treatment and prevention: https://t.co/oCx2OJ51Yr
It's #WorldAMRAwarenessWeek and we are highlighting the role of vaccines in reducing the emergence and spread of #AMR
Vaccines and the correct use of antimicrobial medicines help preserve the effectiveness of vital medical treatments
Learn more ⤵️
CEPI is the world's leading funder of #Lassa vaccine research 💉🌍
But what is Lassa fever? Who does it affect? And what symptoms does it cause? https://t.co/LbooxWwkrx
📣A vaccine against Chikungunya has secured regulatory approval for the first time.
The next step is even more important: making the vaccine accessible to those in endemic countries who are most at risk from the disease, writes CEPI CEO @DrRHatchett🔽
https://t.co/HV167sB1qT
📣Calling all experts in #globalhealth and infectious diseases! Our special collection 'Global Health: Travel Vaccines and Infectious Disease' is now open, in partnership with @TAInfDis🌍💉🦠
🔸 Guest Editor: Dr Nelson Agudelo @OUHealth
🔸 Info: https://t.co/seEWzDY5Yo
📣Calling all experts in #globalhealth and infectious diseases! Our special collection 'Global Health: Travel Vaccines and Infectious Disease' is now open, in partnership with @TAVaccinesImm🌍💉🦠
🔸 Guest Editor: Dr Nelson Agudelo @OUHealth
🔸 Full info: https://t.co/c1qlSPtvZt
A #Chikungunya vaccine is nearing approval. CEPI & EU investment is specifically designed to accelerate access for people living in endemic countries to a shot which had been developed primarily for the tourist market in rich countries.
https://t.co/RGA720Q9WJ
The incidence of #dengue has increased 30-fold over the last 50 years, leaving half the world at risk.
Prevention is the top priority and there are vaccine candidates in the pipeline. Here’s what you need to know: https://t.co/GoanqD3f1A
💉🧠 With recent exciting developments in the field of #glioma#immunotherapy, I’m happy to share our review on therapeutic vaccine strategies for the treatment of diffusely infiltrating gliomas in collaboration with Nick Gonzalez Castro, @ChanningPooley, and @SydneyDDumont!